LOG IN

REDHILL BIOPHARMA LTD - ADR

Versiunea din 3 octombrie 2024 02:46, autor: 127.0.0.1 (discuție) (The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei REDHILL BIOPHARMA LTD - ADR listata cu simbolul US.RDHL

Descriere companieModificare

Redhill Biopharma Ltd (https://www.redhillbio.com/) is an Israel-basedis a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The Company promotes three gastrointestinal drugs in the US: Movantik, Talicia and Aemcolo. Key programs in it pipeline of late-stage clinical assets include: opaganib (Yeliva) and RHB-107 for multiple indications including COVID-19, RHB-204 for pulmonary nontuberculous mycobacteria (NTM) disease and RHB-104 for Crohn's disease.

Grafic actiuni companieModificare

Ultimele stiri despre REDHILL BIOPHARMA LTD - ADR (US.RDHL)Modificare

Adus de la „https://wiki.tradeville.ro/index.php?title=REDHILL_BIOPHARMA_LTD_-_ADR&oldid=448957”